Revolutionary AI Tool POLYGON Accelerates Cancer Drug Discovery
UC San Diego researchers develop an AI platform that streamlines the creation of multi-target cancer treatments, potentially reducing side effects and discovery time.
- POLYGON, a new AI platform, simulates complex drug discovery processes, enabling the rapid synthesis of 32 new cancer drug candidates.
- The AI tool focuses on multi-target molecules, aiming to replicate the benefits of combination therapies with fewer side effects.
- Developed by UC San Diego, POLYGON is unique in its ability to generate drug formulas that target multiple disease proteins simultaneously.
- The platform is open source, offering unprecedented access to advanced drug discovery tools for researchers worldwide.
- Researchers emphasize the potential of AI to transform drug development, foreseeing significant advancements in the next decade.
ScienceDaily 